Deconstructing Postoperative Analgesia for Gynecologic Malignancy Surgery: Stand-Alone Intrathecal Morphine
- PMID: 37590797
- DOI: 10.1213/ANE.0000000000006455
Deconstructing Postoperative Analgesia for Gynecologic Malignancy Surgery: Stand-Alone Intrathecal Morphine
Conflict of interest statement
The authors declare no conflicts of interest.
Comment on
-
The Effect of Intrathecal Morphine on Postoperative Opioid Consumption in Patients Undergoing Abdominal Surgery for Gynecologic Malignancy: A Randomized Sham-Controlled Trial.Anesth Analg. 2023 Sep 1;137(3):525-533. doi: 10.1213/ANE.0000000000006358. Epub 2023 Jan 20. Anesth Analg. 2023. PMID: 36727850 Clinical Trial.
References
-
- Nelson G, Bakkum-Gamez J, Kalogera E, et al. Guidelines for perioperative care in gynecologic/oncology: Enhanced Recovery After Surgery (ERAS) Society recommendations-2019 update. Int J Gynecol Cancer. 2019;29:651–668.
-
- Ore AS, Shear MA, Liu FW, et al. Adoption of enhanced recovery after laparotomy in gynecologic oncology. Int J Gynecol Cancer. 2020;30:122–127.
-
- Ljungqvist O, Scott M, Fearon KC. Enhanced recovery after surgery: a review. JAMA Surg. 2017;152:292–298.
-
- Wagemans MF, Scholten WK, Hollmann MW, Kuipers AH. Epidural anesthesia is no longer the standard of care in abdominal surgery with ERAS. What are the alternatives? Minerva Anestesiol. 2020;86:1–79-1088.
-
- Meylan N, Elia N, Lysakowski C, Tramer MR. Benefit and risk of intrathecal morphine without local anaesthetic in patients undergoing major surgery: meta-analysis of randomized trials. Br J Anaesth. 2009;102:156–167.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources